Aaron Novikoff

591 total citations
15 papers, 224 citations indexed

About

Aaron Novikoff is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, Aaron Novikoff has authored 15 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Aaron Novikoff's work include Diabetes Treatment and Management (11 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacology and Obesity Treatment (5 papers). Aaron Novikoff is often cited by papers focused on Diabetes Treatment and Management (11 papers), Receptor Mechanisms and Signaling (6 papers) and Pharmacology and Obesity Treatment (5 papers). Aaron Novikoff collaborates with scholars based in Germany, United States and Slovakia. Aaron Novikoff's co-authors include Timo D. Müller, Gerald Grandl, Brian Finan, Matthias H. Tschöp, Richard D. DiMarchi, Maximilian Kleinert, Kerstin Stemmer, David A. D’Alessio, Jonathan D. Douros and Kimberley El and has published in prestigious journals such as Diabetologia, Nature Reviews Endocrinology and Trends in Endocrinology and Metabolism.

In The Last Decade

Aaron Novikoff

13 papers receiving 219 citations

Peers

Aaron Novikoff

EDM

SURGE

PHARM

PHYSI

David C. D. Hope United Kingdom

Brian A. Droz United States

Myriam Masseboeuf France

Jonathan W. Day United States

Sigrid Jall Germany

Shahar Azar Israel

Eiji Ueyama Japan

Joyceline Cuenco United Kingdom

Weiwen Hu China

Lisa Getty‐Kaushik United States

David C. D. Hope United Kingdom

Aaron Novikoff

145 ×0.9

EDM

69 ×0.7

74 ×1.1

SURGE

56 ×0.9

PHARM

48 ×0.9

PHYSI

Citations per year, relative to Aaron Novikoff Aaron Novikoff (= 1×) peers David C. D. Hope

Countries citing papers authored by Aaron Novikoff

Since Specialization

Citations

This map shows the geographic impact of Aaron Novikoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Novikoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Novikoff more than expected).

Fields of papers citing papers by Aaron Novikoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Novikoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Novikoff. The network helps show where Aaron Novikoff may publish in the future.

Co-authorship network of co-authors of Aaron Novikoff

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Novikoff. A scholar is included among the top collaborators of Aaron Novikoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Novikoff. Aaron Novikoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sun, Na, Ahmed Khalil, Arkadiusz Liśkiewicz, et al.. (2025). Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Molecular Metabolism. 96. 102136–102136. 1 indexed citations

Beck, Andreas, Aaron Novikoff, Peter S. Reinach, et al.. (2025). GLP-1/GIP/GCG receptor triagonist (IUB447) enhances insulin secretion via GLP-1 receptor and Gαq signalling pathway in mice. Diabetologia. 68(11). 2567–2580. 1 indexed citations

Novikoff, Aaron & Timo D. Müller. (2025). One small molecule for man, one giant leap for mankind with obesity. Med. 6(12). 100924–100924.

Novikoff, Aaron & Timo D. Müller. (2025). Tirzepatide differentially affects body weight in mice and humans. Nature Reviews Endocrinology. 21(8). 462–463. 1 indexed citations

Grandl, Gerald, Aaron Novikoff, Xue Liu, & Timo D. Müller. (2024). Recent achievements and future directions of anti-obesity medications. The Lancet Regional Health - Europe. 47. 101100–101100. 5 indexed citations

Novikoff, Aaron, Gerald Grandl, Xue Liu, & Timo D. Müller. (2024). Why are we still in need for novel anti-obesity medications?. The Lancet Regional Health - Europe. 47. 101098–101098. 6 indexed citations

Novikoff, Aaron & Timo D. Müller. (2024). Antagonizing GIPR adds fire to the GLP-1R flame. Trends in Endocrinology and Metabolism. 35(7). 566–568. 8 indexed citations

Novikoff, Aaron & Timo D. Müller. (2024). Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t. Physiology. 39(3). 142–156. 5 indexed citations

Novikoff, Aaron & Timo D. Müller. (2023). The molecular pharmacology of glucagon agonists in diabetes and obesity. Peptides. 165. 171003–171003. 34 indexed citations

10.

El, Kimberley, Jonathan D. Douros, Francis S. Willard, et al.. (2023). The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. Nature Metabolism. 5(6). 945–954. 74 indexed citations

11.

Novikoff, Aaron & Timo D. Müller. (2023). SURMOUNTing body weight barriers in type 2 diabetes. Med. 4(12). 849–851.

12.

Khajavi, Noushafarin, Andreas Beck, Anouar Belkacemi, et al.. (2022). TRPM7 kinase is required for insulin production and compensatory islet responses during obesity. JCI Insight. 8(3). 11 indexed citations

13.

Novikoff, Aaron, Shannon O’Brien, Gerald Grandl, et al.. (2021). Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists. Molecular Metabolism. 49. 101181–101181. 60 indexed citations

14.

Jall, Sigrid, Meri De Angelis, Anne‐Marie Lundsgaard, et al.. (2020). Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity. Diabetologia. 63(6). 1236–1247. 9 indexed citations

15.

Grandl, Gerald, Aaron Novikoff, Richard D. DiMarchi, Matthias H. Tschöp, & Timo D. Müller. (2019). Gut Peptide Agonism in the Treatment of Obesity and Diabetes. Comprehensive physiology. 10(1). 99–124. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact